Fig. 2. Least squares mean of the percent change in LDL-C after 12 and 24 weeks of treatment with ezetimibe/rosuvastatin or rosuvastatin.
LDL-C, low-density lipoprotein cholesterol.
*p-values from analysis of covariance test.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.